Table 2. Univariate comparison for baseline clinical and imaging data.
Poor outcome (mRS score, 3–6) | Good outcome (mRS score, 0–2) | p Value | |
---|---|---|---|
(n = 56) | (n = 24) | ||
Age, y | 71.5 ± 11.1 | 63.9 ± 10.0 | 0.005 |
Female, % | 23 (41.1) | 10 (41.7) | 0.960 |
Additional ICA occlusion, % | 22 (39.3) | 1 (4.2) | 0.001 |
OIT, min | 176.5 (110–237) | 150.5 (86.8–245) | 0.605 |
ONT, min | 203.5 (135–271) | 170 (129–252) | 0.755 |
Risk factors | |||
Hypertension, n (%) | 40 (71.4) | 14 (58.3) | 0.252 |
Diabetes, % | 10 (17.9) | 1 (4.2) | 0.103 |
Atrial fibrillation, % | 34 (60.7) | 14 (58.3) | 0.842 |
hyperlipidemia, % | 28 (50.0) | 7 (29.2) | 0.085 |
Smoking, % | 13 (23.2) | 7 (29.2) | 0.573 |
History of stroke/ TIA, % | 7 (12.5) | 3 (12.5) | 1.000 |
Previous use of antiplatelet, % | 5 (8.9) | 4 (16.7) | 0.315 |
baseline serum glucose, mg/mL | 7.8 ± 3.6 | 6.8 ± 1.3 | 0.193 |
baseline SBP, mm Hg | 148.3 ± 22.0 | 148.3 ± 21.5 | 0.994 |
baseline DBP, mm Hg | 82.0 ± 12.5 | 85.3 ± 13.8 | 0.300 |
Baseline NIHSS | 14 (12–18) | 8.5 (5.25–12.0) | <0.001 |
Baseline infarct volume, mL | 73.6 (36.9–111.1) | 46.9(23.0–70.0) | 0.001 |
Baseline hypoperfusion volume, mL | 153.2 (100.7–215.4) | 119.4 (75.8–146.2) | 0.029 |
Baseline mismatch ratio, % | 2.89 ± 2.38 | 3.61 ± 3.80 | 0.350 |
rLMC-P | 11 (8.25–13) | 14 (12.3–15.8) | <0.001 |
rLMC-M | 14 (12–16) | 17 (14–18) | <0.001 |
ICA: internal carotid artery; OIT: onset to imaging time; ONT: onset to needle time; TIA: transient ischemic attack; SBP: systolic blood pressure; DBP: diastolic blood pressure; NIHSS: national institute of health stroke scale